Parexel Simplifies Access to Knowledge

May 7, 2019

A new report by the Economist Intelligence Unit (EIU) and commissioned by Parexel International Corporation reveals that new innovations in drug development have a positive impact on clinical trial timelines, likelihood of market launch, and inclusion on selected payer formularies.

Previous Video
Accelerated Pathways – Alberto Grignolo
Accelerated Pathways – Alberto Grignolo

Next Video
Parexel Analyzes the Real-World Data Revolution and Role of Early Payer Engagement
Parexel Analyzes the Real-World Data Revolution and Role of Early Payer Engagement

Richard Tolley, Vice President Integrated Market Access Solutions at Parexel discusses a recent roundtable ...